Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK ® for the Treatment of Dystrophic Epidermolysis Bullosa



[
Krystal Biotech Receives Positive CHMP Opinion for VYJUVEK ® for the Treatment of Dystrophic Epidermolysis Bullosa
[og_img]
https://www.investing.com/news/press-releases/krystal-biotech-receives-positive-chmp-opinion-for-vyjuvek–for-the-treatment-of-dystrophic-epidermolysis-bullosa-93CH-3899423


Investing.com

Latest articles

spot_imgspot_img

Related articles

spot_imgspot_img